EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study

Ruth Simmons, Annabel A Powell, Samreen Ijaz, Sema Mandal, Justin Shute, Yasmin Mohammadi, Michael Lattimore, Kelsey McOwat, Hannah L Moore, Aisling O'Rourke, Monica Desai, John Macleod und 7 weitere

British Journal of General Practice · 2025-02 · 75 (751) · e122-e128

DOI: 10.3399/bjgp.2024.0219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of General Practice, online erschienen am 05.07.2024. Verfasst von Ruth Simmons und 18 weiteren Autor:innen. Beteiligte Einrichtung: UK Health Security Agency, London, UK. Hauptthemen laut MEDLINE: Mass Screening, Primary Health Care, Hepacivirus, Hepatitis C Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Birth cohort screening has been implemented in some countries to identify the potentially ‘missed population’ of people with undiagnosed chronic hepatitis C virus (HCV) who may not be found through targeted approaches.

Aim

To determine uptake of HCV antibody testing using an oral swab screening method, the overall yield, whether those testing positive had risk markers in their primary care record, and the cost per case detected. Design and setting This was a pilot screening study set in general practices in the Southwest of England, Yorkshire and Humber, and South London.

Method

Participants consenting were sent an oral swab kit in the post and saliva samples were tested for antibodies to HCV.

Results

In total, 16 436/98 396 (16.7%) patients consented and were sent an oral swab kit. Of these, 12 216 (12.4%) returned a kit, with 31 participants (yield 0.03%) testing positive for HCV antibodies. Of those positive, 14/35 (45%) had a risk marker for HCV on their primary care record. Two (yield 0.002%) were confirmed RNA positive and referred for treatment, both had HCV risk markers. The cost per case was £16 000 per HCV antibody detected and £247 997 per chronic HCV detected.

Conclusion

Wide-scale screening could be delivered and identify people infected with HCV, however, most of these individuals could have been detected through lower-cost targeted screening. The yield and cost per case found in patients were substantially worse than model estimates and targeted screening studies. Birth cohort screening should not be rolled out in primary care in England.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass ScreeningPrimary Health CareHepacivirusHepatitis C AntibodiesHepatitis C, ChronicHumansPilot ProjectsFemaleMaleUnited KingdomSalivaMiddle AgedAdultPostal ServiceCohort Studies

Stichwörter der Autor:innen

birth cohort screeningcost per case foundhepatitis Cprimary health care

Substanzen

Hepatitis C Antibodies

Autor:innen und Institutionen

  • UK Health Security Agency, London, UK.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Centre for Academic Primary Care, Population Health Sciences, University of Bristol, Bristol.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol and NIHR Health Protection Research Unit in Evaluation of Interventions, University of Bristol, Bristol.
  • Centre for Immunobiology, Queen Mary University of London, London, UK.

ORCID-Profile: Kirsty Roberts

Zitieren

APA

Simmons, R., Powell, A. A., Ijaz, S., Mandal, S., Shute, J., Mohammadi, Y., Lattimore, M., McOwat, K., Moore, H. L., O'Rourke, A., Desai, M., Macleod, J., Asgharzadeh, A., Ward, Z., Vickerman, P., Harris, R. J., Foster, G. R., Roberts, K., & Hickman, M. (2025). Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study. British Journal of General Practice, 75(751), e122-e128. https://doi.org/10.3399/bjgp.2024.0219

Vancouver

Simmons R, Powell AA, Ijaz S, Mandal S, Shute J, Mohammadi Y, et al. Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study. British Journal of General Practice. 2025;75(751):e122-e128. doi:10.3399/bjgp.2024.0219

BibTeX
@article{Simmons2025,
  author = {Simmons, Ruth and Powell, Annabel A and Ijaz, Samreen and Mandal, Sema and Shute, Justin and Mohammadi, Yasmin and Lattimore, Michael and McOwat, Kelsey and Moore, Hannah L and O'Rourke, Aisling and Desai, Monica and Macleod, John and Asgharzadeh, Asra and Ward, Zoe and Vickerman, Peter and Harris, Ross J and Foster, Graham R and Roberts, Kirsty and Hickman, Matthew},
  title = {Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study},
  journal = {British Journal of General Practice},
  year = {2025},
  volume = {75},
  number = {751},
  pages = {e122--e128},
  doi = {10.3399/bjgp.2024.0219}
}
Kostenlos starten →